Menu
Deciding which project to progress when the technologies and applications are diverse is a challenge that faces many innovation managers. In this guest blog Mark
Pharmaceutical R&D is a complex, long and expensive task with a high project attrition rate. Only 5% of drug projects, that reach the stage of
Have your say / Follow us
R&D Today is the outreach site for the Research and Development Management Association, a charitable organisation that supports research, best practice and innovation. www.radma.net
© Copyright R&D Today
All rights reserved.